top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

GSK and Flagship Pioneering Announce $720M Collaboration to Develop Transformational Medicines and Vaccines

London and Cambridge, MA, July 29, 2024 (PRNewswire) -- GSK and Flagship Pioneering are collaborating to discover and develop transformational medicines and vaccines, beginning with respiratory and immunology. The initial exploration phase will be funded with a joint $150 million to identify promising concepts. Flagship and its bioplatform companies could receive up to $720 million per acquired program in milestones and royalties.


Read full article here.

Recent Posts

See All

コメント


Life Science Headlines
bottom of page